Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
34.81
+0.88 (2.59%)
At close: Jun 26, 2026, 4:00 PM EDT
35.51
+0.70 (2.01%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Beam Therapeutics Employees
Beam Therapeutics had 522 employees as of March 31, 2026. The number of employees increased by 11 or 2.15% since the number was last reported on December 31, 2025.
Employees
522
Change
11
Growth
2.15%
Revenue / Employee
$314,197
Profits / Employee
-$126,398
Market Cap
3.46B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Crinetics Pharmaceuticals | 594 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| uniQure | 221 |
| Catalyst Pharmaceuticals | 182 |
BEAM News
- 8 days ago - Beam Therapeutics announces U.S. FDA clearned IND application for BEAM-304 - TheFly
- 8 days ago - Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration - GlobeNewsWire
- 9 days ago - The Healthcare M&A Wave - Forbes
- 23 days ago - Beam Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Beam Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Beam Therapeutics presents Phase 1/2 data for BEAM-302 - TheFly
- 5 weeks ago - Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1 - PRNewsWire